These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23575425)

  • 1. [Open innovation for pharmaceutical industries].
    Matsumoto Y; Sakata T
    Nihon Yakurigaku Zasshi; 2013 Apr; 141(4):199-204. PubMed ID: 23575425
    [No Abstract]   [Full Text] [Related]  

  • 2. Open innovation and intellectual property: time for a reboot?
    Judd DB
    Drug Discov Today; 2013 Oct; 18(19-20):907-9. PubMed ID: 23958455
    [No Abstract]   [Full Text] [Related]  

  • 3. [Open innovation for Japanese pharmaceutical companies].
    Hoshino T
    Nihon Yakurigaku Zasshi; 2013 Oct; 142(4):184-9. PubMed ID: 24107523
    [No Abstract]   [Full Text] [Related]  

  • 4. [Open innovation and licensing in the pharmaceutical industry].
    Yamasaki M
    Nihon Yakurigaku Zasshi; 2013 Jul; 142(1):28-31. PubMed ID: 23842225
    [No Abstract]   [Full Text] [Related]  

  • 5. [Open innovation: public-private partnerships in pharmaceutical R&D].
    Uchibayashi N
    Nihon Yakurigaku Zasshi; 2013 Jul; 142(1):32-8. PubMed ID: 23842226
    [No Abstract]   [Full Text] [Related]  

  • 6. Can open-source drug R&D repower pharmaceutical innovation?
    Munos B
    Clin Pharmacol Ther; 2010 May; 87(5):534-6. PubMed ID: 20407458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reinventing bioinnovation.
    Kaitin KI; Honig PK
    Clin Pharmacol Ther; 2013 Sep; 94(3):279-83. PubMed ID: 23963211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deconstructing the drug development process: the new face of innovation.
    Kaitin KI
    Clin Pharmacol Ther; 2010 Mar; 87(3):356-61. PubMed ID: 20130565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open partnering of integrated drug discovery: continuing evolution of the pharmaceutical model.
    Hutchins S; Torphy T; Muller C
    Drug Discov Today; 2011 Apr; 16(7-8):281-3. PubMed ID: 21335101
    [No Abstract]   [Full Text] [Related]  

  • 10. [Strategic construction of an innovative drug development pipeline by industry-academia cooperation - consortium for drug innovation in the Tokai region of Japan].
    Akaike A
    Nihon Yakurigaku Zasshi; 2014 May; 143(5):254-9. PubMed ID: 24813797
    [No Abstract]   [Full Text] [Related]  

  • 11. Open innovation: share or die..
    Talaga P
    Drug Discov Today; 2009 Nov; 14(21-22):1003-5. PubMed ID: 19778629
    [No Abstract]   [Full Text] [Related]  

  • 12. [Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project].
    Fujita Y
    Nihon Yakurigaku Zasshi; 2013 Aug; 142(2):89-95. PubMed ID: 23934529
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug discovery in the next decade: innovation needed ASAP.
    Bennani YL
    Drug Discov Today; 2011 Sep; 16(17-18):779-92. PubMed ID: 21704185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could pharma open its drug freezers?
    Mullard A
    Nat Rev Drug Discov; 2011 Jun; 10(6):399-400. PubMed ID: 21629278
    [No Abstract]   [Full Text] [Related]  

  • 15. A measure of productivity and innovation in the pharmaceutical industry 2011-2015.
    Harrison R
    Drugs Today (Barc); 2016 Nov; 52(11):627-633. PubMed ID: 28112281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The promise of open innovation in drug discovery: an industry perspective.
    Rees S
    Future Med Chem; 2015; 7(14):1835-8. PubMed ID: 26420551
    [No Abstract]   [Full Text] [Related]  

  • 17. Why and how have drug discovery strategies in pharma changed? What are the new mindsets?
    Mignani S; Huber S; Tomás H; Rodrigues J; Majoral JP
    Drug Discov Today; 2016 Feb; 21(2):239-49. PubMed ID: 26376356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open innovation platforms to boost pharmaceutical collaborations: evaluating external compounds for desired biological activity.
    Nilsson N; Felding J
    Future Med Chem; 2015; 7(14):1853-9. PubMed ID: 26393392
    [No Abstract]   [Full Text] [Related]  

  • 19. Grants4Targets: an open innovation initiative to foster drug discovery collaborations.
    Dorsch H; Jurock AE; Schoepe S; Lessl M; Asadullah K
    Nat Rev Drug Discov; 2015 Jan; 14(1):74-6. PubMed ID: 25430867
    [No Abstract]   [Full Text] [Related]  

  • 20. Open innovation in early drug discovery: roadmaps and roadblocks.
    Reichman M; Simpson PB
    Drug Discov Today; 2016 May; 21(5):779-88. PubMed ID: 26743597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.